Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons

被引:35
作者
Briggs, DJ [1 ]
Dreesen, DW
Nicolay, U
Chin, JE
Davis, R
Gordon, C
Banzhoff, A
机构
[1] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA
[2] Univ Georgia, Coll Vet Med, Athens, GA USA
[3] Aventis Behring, Marburg, Germany
[4] ChironBehring GmbH, Marburg, Germany
关键词
rabies; PCECV; HDCV;
D O I
10.1016/S0264-410X(00)00342-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The equivalence and interchangeability of Purified Chick Embryo Cell Culture Rabies Vaccine (PCECV) to Human Diploid Cell Culture Rabies Vaccine (HDCV) and the immunogenicity of a reduced post-exposure regimen with PCECV was investigated. Statistical analyses revealed no difference (P less than or equal to 0.05) between the geometric mean titers (GMT) on day 49 of subjects that received PCECV or HDCV. In Year 2, subjects were boosted with one or two dose(s) of PCECV. No significant difference (P less than or equal to 0.05) was detected between the GMT of the two groups on days 7 and 365 post-booster. Subjects that received HDCV initially developed an adequate anamnestic response to PCECV. On day 21 post-booster, the GMT of subjects that received two boosters was higher (151.6 IU/ml) than those that received one booster (120.9 IU/ml). However, this difference may not be clinically significant. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1055 / 1060
页数:6
相关论文
共 16 条
[1]  
BRIGGS D, 2000, WHO B, V78, P693
[2]  
DIETZSCHOLD B, 1991, CRIT REV IMMUNOL, V10, P427
[3]   IMMUNE COMPLEX-LIKE DISEASE IN 23 PERSONS FOLLOWING A BOOSTER DOSE OF RABIES HUMAN-DIPLOID CELL VACCINE [J].
DREESEN, DW ;
BERNARD, KW ;
PARKER, RA ;
DEUTSCH, AJ ;
BROWN, J .
VACCINE, 1986, 4 (01) :45-49
[4]   2-YEAR COMPARATIVE TRIAL ON THE IMMUNOGENICITY AND ADVERSE-EFFECTS OF PURIFIED CHICK-EMBRYO CELL RABIES VACCINE FOR PRE-EXPOSURE IMMUNIZATION [J].
DREESEN, DW ;
FISHBEIN, DB ;
KEMP, DT ;
BROWN, J .
VACCINE, 1989, 7 (05) :397-400
[5]   NEUROLOGIC COMPLICATIONS OF SEMPLE-TYPE RABIES VACCINE - CLINICAL AND IMMUNOLOGICAL STUDIES [J].
HEMACHUDHA, T ;
PHANUPHAK, P ;
JOHNSON, RT ;
GRIFFIN, DE ;
RATANAVONGSIRI, J ;
SIRIPRASOMSUP, W .
NEUROLOGY, 1987, 37 (04) :550-556
[6]   EFFECT OF ONE BOOSTER DOSE IN ANTIRABIES VACCINATION [J].
LEMOS, HN ;
DESOUZA, MM ;
DECAMPOS, HHV ;
DEABREU, VLV ;
SOARES, ICG ;
REIS, W .
BIOLOGICALS, 1992, 20 (03) :171-175
[7]  
Rohmel J, 1998, STAT MED, V17, P1703
[8]   A COMPARISON OF THE 2 ONE-SIDED TESTS PROCEDURE AND THE POWER APPROACH FOR ASSESSING THE EQUIVALENCE OF AVERAGE BIOAVAILABILITY [J].
SCHUIRMANN, DJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1987, 15 (06) :657-680
[9]  
Smith J S, 1973, Monogr Ser World Health Organ, P354
[10]   Gender differences in some host defense mechanisms [J].
Spitzer, JA .
LUPUS, 1999, 8 (05) :380-383